NCT03734913: A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors |
|
|
| Unknown status | 1 | 65 | RoW | ZSP1602 | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | Basal Cell Carcinoma, Medulloblastoma, Adenocarcinoma of Esophagogastric Junction, Small Cell Lung Cancer, Neuroendocrine Neoplasm, Glioblastoma | 07/21 | 07/21 | | |
